Editorial Board

Editors (2)

Prof. Dr. Arne Skerra
Chair of Biological Chemistry, Technical University of Munich, Emil-Erlenmeyer-Forum 5, 85354 Freising (Weihenstephan), Germany
Interests: alternative scaffolds; antibody engineering; antibody humanization; anticalins; protein pharmacology; protein design; protein crystallography
Prof. Dr. Linqi Zhang *
Section Editor-in-Chief
Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China
Interests: antibody; vaccine; viruses
* Section: Humoral Immunity

Advisory Board (1)

Prof. Dr. Ronald P. Taylor
Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesvile, VA 22908, USA
Interests: ADCC; CDC; complement and Fc receptors; immunotherapy of cancer; antigenic modulation
Special Issues, Collections and Topics in MDPI journals

Editorial Board Members (98)

Prof. Dr. William R. (Bill) Strohl
BiStro Biotech Consulting, Bridgewater, NJ, USA
Interests: antibodies; Fc engineering; Fc fusion proteins; bispecific antibodies; IgMs
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Scott Alper
1. Department of Immunology and Genomic Medicine and Center for Genes, Environment, and Health, National Jewish Health, Denver, CO 80206, USA
2. Department of Immunology and Microbiology, University of Colorado Denver School of Medicine, Anschutz, CO 80206, USA
Interests: basic immunology; inflammation; innate immunity; molecular genetics
Dr. Luis Alvarez-Vallina
Immuno-Oncology and Immunotherapy Group, Research Institute Hospital 12 de Octubre (I+12), Madrid, Spain
Interests: cancer Immunotherapy; bispecific antibodies; immunostimulatory antibodies; in situ secretion of antibodies
Dr. Adam Barb
Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA
Interests: antibodies; Fc gamma receptors; structural biology; N-glycosylation; NK cells; monocytes; mass spectrometry
Prof. Dr. Jagadeesh Bayry
1. Institut National de la Santé et de la Recherche Médicale, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 75006 Paris, France
2. Department of Biological Sciences & Engineering, Indian Institute of Technology Palakkad, Palakkad 678623, India
Interests: immunology; immune homeostasis; immunotherapy; host-pathogen interaction
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Stephen A. Beers
Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton Faculty of Medicine, Southampton, UK
Interests: antibody drugs; antibody immunotherapy; cancer immunology; antibody effector functions; immunomodulatory antibodies; tumour microenvironment; Fc gamma receptors; macrophages; antibody selection, design and preclinical development
Prof. Dr. Itai Benhar
The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel
Interests: antibody engineering; phage display antibodies; bispecific antibodies; therapeutic monoclonal antibodies; drug-carrying nanomedicines; medicinal chemistry; GPCR-specific antibodies; biotechnology; cell biology; antibodies; phage display; cancer research; cell culture; monoclonal antibodies; cloning; antigen; recombinant antibodies
Dr. Philippe Billiald
Institut Paris-Sud d'Inovation Thérapeutique, Université Paris-Saclay, Paris, France
Interests: antibody engineering; humanization; pharmaceutical development of therapeutic antibodies; anti-thrombotic antibodies; venoms and antivenoms
Dr. Thomas Böldicke

Helmholtz-Centre for Infection Research, Structure and Function of Proteins, Inhoffenstraße 7, D 38124 Braunschweig, Germany
Interests: antibody engineering; selection of human antibodies; cancer therapy; intracellular antibodies
Special Issues, Collections and Topics in MDPI journals
Dr. Nathalie Bonnefoy
IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, 34298 Montpellier, France
Interests: oncoimmunology; immunotherapy; tumor microenvironment; tumor immunity, therapeutic antibodies
Back to TopTop